Evidence map›Paper›PMID 26386602›Full record

ArticleBioorganic & medicinal chemistry letters2015

Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.

Eugene Camerino, Dawn M Wong, Fan Tong, Florian Körber, Aaron D Gross, Rafique Islam, Elisabet Viayna, James M Mutunga, Jianyong Li, Maxim M Totrov and 2 more

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Synthesis and Structure ofMolecules (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Article
  10. CFJournal of the American Chemical Society · 2017
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Eugene CamerinoDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Dawn M WongDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Fan TongDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Florian KörberDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Aaron D GrossDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Rafique IslamDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Elisabet ViaynaDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
James M MutungaDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Jianyong LiDepartment of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Maxim M TotrovMolsoft LLC, 11199 Sorrento Valley Road, San Diego, CA 92121, USA.
Jeffrey R BloomquistDepartment of Entomology and Nematology, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.
Paul R CarlierDepartment of Chemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Virginia Tech · USUniversity of Florida · USMolsoft (United States) · US

Funding

Development of vector-specific, resistance-breaking insecticides to reduce malariR01AI082581 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI CARLIER, PAUL R · 2009 to 2013
$3.4M
NIAID NIH HHS AI082581NIAID NIH HHS R01 AI082581
6 · The paper itself

Abstract

Malaria is a devastating disease in sub-Saharan Africa, and current vector control measures are threatened by emerging resistance mechanisms. With the goal of developing new, selective, resistance-breaking insecticides we explored α-fluorinated methyl ketones as reversible covalent inhibitors of Anopheles gambiae acetylcholinesterase (AgAChE). Trifluoromethyl ketones 5 demonstrated remarkable volatility in microtiter plate assays, but 5c,e-h exhibited potent (1-100 nM) inhibition of wild type (WT) AgAChE and weak inhibition of resistant mutant G119S mutant AgAChE. Fluoromethyl ketones 10c-i exhibited submicromolar to micromolar inhibition of WT AgAChE, but again only weakly inhibited G119S AgAChE. Interestingly, difluoromethyl ketone inhibitors 9c and 9g had single digit nanomolar inhibition of WT AgAChE, and 9g had excellent potency against G119S AgAChE. Approach to steady-state inhibition was quite slow, but after 23 h incubation an IC50 value of 25.1 ± 1.2 nM was measured. We attribute the slow, tight-binding G119S AgAChE inhibition of 9g to a balance of steric size and electrophilicity. However, toxicities of 5g, 9g, and 10g to adult A. gambiae in tarsal contact, fumigation, and injection assays were lower than expected based on WT AgAChE inhibition potency and volatility. Potential toxicity-limiting factors are discussed.

Indexed as

AcetylcholinesteraseAnimalsAnophelesCarbamatesDose-Response Relationship, DrugEnzyme InhibitorsHumansKetonesMolecular StructureMutationStructure-Activity RelationshipAcetylcholinesteraseCarbamatesEnzyme InhibitorsKetonesAcetylcholinesteraseAnopheles gambiaeFluorinated ketonesMalariaTrifluoroketones

Identifiers

PMID26386602
PMCPMC4593063
OpenAlexW1442755648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.